Harnessing Biopolymer Gels for Theranostic Applications: Imaging Agent Integration and Real-Time Monitoring of Drug Delivery

1. Introduction

Biopolymer gels have gained significant attention in recent years for their potential use in drug delivery platforms and theranostic applications. Biocompatibility and biodegradability are fundamental necessities for biomedical applications, and biopolymeric hydrogels are especially valuable in the organization of medications and theranostics because of their capacity to retain and hold a significant measure of water and natural media [1]. Theranostic viability can be expanded by reorganization drug loading and controlling delivery attributes under specific biological feeling conditions as per the exceptional permeable organization construction of hydrogels in light of biopolymers [1]. Since biopolymers arrive in an extensive variety of miniature/nanogel structures that are great for the vast majority harmless to the ecosystem applications, they are believed to be a decent choice for tending to biocompatibility and biodegradability challenges [2]. The capability of biopolymer-based miniature/nanogels as medication transporters in biomedical applications has been researched; studies have featured the utilization of a few biopolymers in the plan of nanogels and their ebb and flow improvements in drug and biomolecule conveyanc applications [1]. The utilization of miniature/nanogels as medication transporters and the creation processes using regular gums and their subordinates are additionally remembered for the audits [1].

Biopolymer-based nanogels have additionally been researched for their capability to ship meds and biomolecules because of their high retention limit of water and natural liquids [3]. The surveys that are examine the utilization of different biopolymer-based miniatures or nanogels for drug conveyance in biomedical applications. They underline the headway made in epitomizing atoms with different restorative purposes utilizing biopolymer-based nano/microgels, as well as clever ways to deal with amalgamation or potentially functionalization to upgrade their conveyance capacities . In current medication, the rising significance of the union among diagnostics and treatments has prompted the development of the theranostic worldview [4]. This coordinated methodology is focused on effectively connecting indicative capacities with restorative activities, empowering the arrangement of individualized and exact treatments for different problems. Huge commitment is held by theranostic procedures for working on understanding results while limiting secondary effects, as they give continuous information on treatment adequacy and illness movement [4].

As the field of medication goes through a worldview change, theranostics rises above conventional limits among determination and treatment. Utilizing a synergistic methodology that consolidates restorative methodologies coordinated by demonstrative strategies, it gives exact and tweaked patient consideration. Through early ailment ID and constant observing of treatment reaction, doctors might fit treatment techniques to every patient's Biopolymer gels certainly stand out lately for their possible use in drug conveyance stages and theranostic applications. Biocompatibility and biodegradability are vital necessities for biomedical applications, and biopolymeric hydrogels are especially helpful in the organization of medications and theranostics because of their capacity to assimilate and hold a significant measure of water and natural media [5]. Theranostic viability can be expanded by advancing medication stacking and controlling delivery qualities under specific organic excitement conditions as indicated by the exceptional permeable organization design of hydrogels in view of biopolymers [5]. Since biopolymers arrive in an extensive variety of miniature/nanogel structures that are great for the majority harmless to the ecosystem applications, they are believed to be a decent choice for tending to biocompatibility and biodegradability challenges [6]. The capability of biopolymer-based miniature/nanogels as medication transporters in biomedical applications has been examined; studies have featured the utilization of a few biopolymers in the plan of nanogels and their ongoing improvements in drug and biomolecule conveyance applications. The utilization of miniature/nanogels as medication transporters and the creation processes using regular gums and their subordinates are additionally remembered for the surveys [6].

Biopolymer-based nanogels have additionally been explored for their capability to move drugs and biomolecules because of their high ingestion limit of water and natural liquids [3]. The audits that are examine the utilization of different biopolymer-based miniatures and nanogels for drug conveyance in biomedical applications. They underline the headway made in epitomizing particles with different restorative purposes utilizing biopolymer-based nano/microgels, as well as clever ways to deal with combination or potentially functionalization to improve their conveyance abilities [7]. In present day medication, the rising significance of the assembly among diagnostics and treatments has prompted the development of the theranostic worldview. This coordinated methodology is focused on effectively connecting demonstrative abilities with restorative activities, empowering the arrangement of individualized and exact treatments for different problems. Tremendous commitment is held by theranostic strategies for working on quiet results while limiting aftereffects, as they give constant information on treatment viability and sickness movement [8].

Finally, theranostics as a worldview change in the field of medication transcends the conventional limits among determination and treatment. It’s anything but a synergistic methodology combining the remedial methodologies coordinated by demonstrative strategies for giving exact and customized patient consideration. Theranostics provides early sickness distinguishing proof and tries to monitor treatment reaction so many treatment methodologies could be adjusted to patients’ particular necessities. Besides, theranostic approaches may improve helpful outcomes by limiting adverse consequences and improving medication circulation. As a result of their excellent features, including biocompatibility, mechanical qualities that may be readily functionalized, and ease of use, theranostic applications have discovered excellent flexibility in biopolymer gels. These gels, which are created with highly regular, synthetic polymers, can be utilized to create a three-layered network structure capable of holding medical substances and imaging probes. The important point is that drug delivery might be prompted by certain physiological signs or external factors through the fabrication of a bio-polymer gel that exhibits a responsive stimulus. As well, compared to traditional drug delivery systems, their organic biodegradability can significantly reduce the problems of toxicity and accumulating for a long time [9].

Theranostic approaches can also help to improve the outcomes of restorative therapy through diminishing unwanted effects and improving drug delivery. These methods have displayed an exceptional flexibility in biopolymer gels due to their peculiarities such as biocompatibility, easily modifiable mechanical characteristics and user friendliness. These natural or artificial polymer gels can be organized into three-layer network structure capable of retaining therapeutic substances and imaging agents. However, it is important to note that bio-polymeric gels are stimuli-responsive and so can deliver drugs upon particular physiological signals or external stimuli [2].

2. Intersecting Diagnosis with Therapy

The word “theranostics”, which combines the words “therapy” and “diagnostics” signifies a concept that emphasizes on integrating diagnostic capabilities with therapeutic treatments. In most cases, traditional means of diagnosis are used prior to making treatment choices hence there is a systematic approach to patient care with a degree of fragmentation involved. Conversely, theranostics fills this void by delivering therapeutic agents alongside providing timely assessment of treatment efficiency [10]. This integration provides broad knowledge about the progression of illnesses and outcome of treatments, thus making it easy for a clinician to interact with patients. This is because theranostic platforms are able to detect an infection at early stages, follow the progress made in treatment and adjust treatment schedules. The use of diagnostic techniques such as imaging or biomarker analysis enables health care practitioners to understand the nature of a disease in terms of its features, molecular markers, spatial distribution of pathologic lesions. These details thereby assist in selecting and planning treatment procedures that are rational, timely, specific and individualized per patient’s requirements. Furthermore, due to continuous interaction between therapies and diagnostics there is flexibility when choosing various approaches to therapy that lead to decreased side effects and development of resistance therapies [10].

3. Biopolymer Gels as Versatile Platforms

Biopolymer gels have been described as biocompatible, tunable and can be functionalized easily making them ideal for a variety of biomedical applications. The positive features of these materials are due to the fact that they create a three-dimensional structure having high water content which is similar to the living tissues extracellular matrix environment through natural and synthetic polymers. As such, they exhibit improved cellular interactions, adjustable mechanical properties, sustained drug release kinetics and other advantageous traits that resemble those of naturally occurring biological systems [11].

The responsive gelation process is one reason among many others why biopolymer gels are highly versatile. When exposed to environmental conditions like changes in pH, temperature variations, light etc., the gelling state may change reversibly. In effecting-controlled release drug delivery this system has precise control over drug release kinetics [12].

Furthermore, biopolymer gels can be designed specifically for certain types of cells or molecules; Reducing off-target effects therefore enables targeted treatment. Biopolymer gels are used because of their porous nature that allows the incorporation of imaging agents. This means images can be captured and treatment response monitored in real time. Biopolymer-based theranostic platforms can be considered as heterogeneous with no restrictions between diagnosis and treatment due to the direct incorporation of imaging agents into the gel structure, thus opening the door to individualized therapeutic approaches [12].

4. Properties and Characteristics of Biopolymer Gels.

Biopolymer gels are multifunctional materials with unique properties that make them ideal for various biomedical applications such as drug delivery, tissue engineering, theranostics, etc. These gels contain natural or synthetic polymers that can form crosslinked networks for so it offers a variety of options [13]. Natural polymers such as alginate, chitosan, collagen, hyaluronic acid, and gelatin have inherent biocompatibility while their man-made counterparts such as polyethylene glycol (PEG), polyvinyl alcohol (PVA) and poly(N-isopropylacrylamide) also offers adjustable for features such as improved mechanical strength. Some important properties affecting the three-dimensional interface structure of biopolymer gels are mechanical properties, pore size distribution, drug release kinetics Manipulation of parameters such as crosslinking density and polymer concentration can be a variety of factors. These gels respond to external stimuli such as temperature pH, or light and therefore can be reversibly modified [14]. These characteristics make them suitable for targeting as their mechanism of action enhances their drug delivery to be useful in a variety of applications Biodegradability and biocompatibility are important considerations when organisms in biopolymers mimic aspects of the extracellular matrix that support cell adhesion and tissue regeneration. Controlled cell degradation is important for gel breakdown into non-toxic products, which is key to maintaining long-term drug release and reducing side effects Furthermore, the scalable mechanism of biopolymer gels is important because it can mimic native tissue and withstand physiological stress. This flexibility makes them useful for a variety of biomedical applications, including clinical and diagnostics [15].

Figure 1. Properties of Biopolymer Gels.

Figure 1. Properties of Biopolymer Gels.

5. Imaging Agents in Theranostic Applications

Imaging modalities play an important role in treatment by providing valuable information on disease location, progression, and treatment response. An overview of the imaging techniques is provided, the clinical importance of imaging materials is discussed, and the various imaging materials commonly used in biomedical research and clinical practice [16].

Imaging techniques covered several techniques based on physical principles, such as X-ray, ultrasound, magnetic resonance, fluorescence, and nuclear imaging and these techniques produce detailed images with spatial and temporal resolution high-quality. Each modality has specific advantages and limitations, making it suitable for different applications in theranostics.

X-ray imaging such as radiography and computed tomography (CT) rely on the contrast of X-rays absorbed by tissues to create detailed images of the body This technique is commonly used to detect bone fractures, diagnose and monitor tumors how doctors intervene [17].

Ultrasound imaging uses high-frequency sound waves to create real-time images of organs and tissues in the body. This noninvasive, portable, and radiation-free technique is suitable for a variety of diagnostic and interventional procedures [18].

MRI technology relies on magnetic fields and radio waves to generate contrast images of soft tissue, ideally suited to imaging the brain, spinal cord and musculoskeletal systems, as well as detect tumors and inflammation [19].

Fluorescence imaging uses fluorescent dyes or materials that emit light upon excitation by an external source, enabling the detection of specific molecular targets, biomarkers, or cellular processes with high sensitivity and specificity [20].

Nuclear imaging modalities, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) use radioactivity for detailed functional imaging to provide quantitative information on tracer uptake, metabolism, and biological distribution important for molecular analysis and anatomical imaging [20].

Among the therapies, the selection of appropriate imaging agents is important for accurate diagnosis, treatment planning, and monitoring of therapeutic response When different imaging modalities and agents are used, individual exposure intervention can benefit from improved outcomes.

Table 1. Imaging agent and there applications.

Imaging Modality	Imaging Agent	Theranostic Application
X-ray Imaging	Iodine-based contrast agents	Diagnosis of bone fractures, detection of tumors, and monitoring therapeutic interventions	[21]
	Barium sulfate	Visualization of gastrointestinal tract for diagnosing conditions like ulcers or tumors
Ultrasound Imaging	Microbubble contrast agents	Assessing blood flow, visualizing organs, and guiding interventional procedures	[22]
	Contrast-enhanced ultrasound	Imaging liver lesions, assessing vascularity in tumors, and diagnosing cardiovascular conditions
Magnetic Resonance Imaging (MRI)	Gadolinium-based contrast agents	Imaging brain, spinal cord, and musculoskeletal system, detecting tumors, and inflammatory processes	[19]
	Superparamagnetic iron oxide nanoparticles (SPIONs)	Targeted drug delivery and imaging of inflammation
Fluorescence Imaging	Fluorescent dyes	Visualizing specific molecular targets, biomarkers, or cellular processes with high sensitivity	[23]
	Quantum dots	Multiplexed imaging of molecular targets for personalized medicine
Nuclear Imaging	Fluorodeoxyglucose (FDG)	Cancer diagnosis and monitoring response to treatment	[24]
	Technetium-99m labeled agents	Imaging myocardial perfusion and diagnosing bone metastases
	Copper-64 labeled nanoparticles	Imaging and tracking of stem cell therapy

Table 1. Imaging agent and there applications.

Imaging Modality	Imaging Agent	Theranostic Application
X-ray Imaging	Iodine-based contrast agents	Diagnosis of bone fractures, detection of tumors, and monitoring therapeutic interventions	[21]
	Barium sulfate	Visualization of gastrointestinal tract for diagnosing conditions like ulcers or tumors
Ultrasound Imaging	Microbubble contrast agents	Assessing blood flow, visualizing organs, and guiding interventional procedures	[22]
	Contrast-enhanced ultrasound	Imaging liver lesions, assessing vascularity in tumors, and diagnosing cardiovascular conditions
Magnetic Resonance Imaging (MRI)	Gadolinium-based contrast agents	Imaging brain, spinal cord, and musculoskeletal system, detecting tumors, and inflammatory processes	[19]
	Superparamagnetic iron oxide nanoparticles (SPIONs)	Targeted drug delivery and imaging of inflammation
Fluorescence Imaging	Fluorescent dyes	Visualizing specific molecular targets, biomarkers, or cellular processes with high sensitivity	[23]
	Quantum dots	Multiplexed imaging of molecular targets for personalized medicine
Nuclear Imaging	Fluorodeoxyglucose (FDG)	Cancer diagnosis and monitoring response to treatment	[24]
	Technetium-99m labeled agents	Imaging myocardial perfusion and diagnosing bone metastases
	Copper-64 labeled nanoparticles	Imaging and tracking of stem cell therapy

6. Importance of Imaging Agents in Theranostics

In theranostics, dual roles are served by imaging agents as diagnostic tools and therapeutic agents, enabling the integration of diagnostics and therapeutics into a unified platform. Through the incorporation of imaging agents directly into therapeutic formulations or delivery vehicles, disease progression can be monitored, treatment response assessed, and therapeutic regimens optimized in real time by clinicians [25]. Non-invasive visualization of drug distribution, pharmacokinetics, and pharmacodynamics is facilitated by imaging agents, allowing for personalized treatment strategies tailored to individual patient profiles. Moreover, early detection of treatment resistance, identification of therapeutic targets, and prediction of treatment outcomes are enabled by imaging agents, thereby improving patient outcomes and reducing healthcare costs [26].

7. Types of Imaging Agents Used

A various imaging agent is available for use in theranostic applications, such as contrast agents, fluorescent dyes and probes, radiotracers, nanoparticles, and molecular probes, each possessing unique properties and applications.

Contrast agents enhance the visibility of anatomical structures or pathological lesions on imaging scans by altering the contrast between tissues. Examples include iodinated contrast agents for X-ray and CT imaging, gadolinium-based contrast agents for MRI, and microbubbles for ultrasound imaging. Fluorescent dyes and probes emit light at specific wavelengths upon excitation by external sources, enabling visualization of molecular targets, cellular processes, and biological interactions [13]. They are commonly used in preclinical research and intraoperative imaging for guiding surgical resection of tumors. Nanoparticles that contain imaging agents such as quantum dots, iron oxide nanoparticles and gold nanoparticles make possible multi-modal imaging and focused drug delivery. They are important as they have more stability, a long time in circulation and can be targeted towards specific sites. Molecular probes have been developed to target disease-specific biomarkers or molecular pathways, thus allowing selective imaging of different diseases. Consequently, they can be tagged with fluorescent dyes, radioactive tracers or MRI contrast agents for substantial results through several imaging methods [20].

Figure 2. Types of Imaging Agents.

Figure 2. Types of Imaging Agents.

8. Integration of Imaging Agents with Biopolymer Gels

Combining biopolymer gels with diagnostic tools improves diagnosis, therapy and monitoring. Signal strength is improved through strategies which enhance biocompatibility with respect to biomedical applications in safety terms.

Different methods have been developed for incorporating imaging agents inside biopolymer gels, allowing multimodal imaging and monitoring therapeutic interventions in real time:

Encapsulation: During gelation, the imaging agents can be enclosed inside the gel matrix via physical entrapment or chemical conjugation. For example, prior to the gel formation, fluorescent dyes, contrast agents or radiotracers can be mixed with polymer solution to ensure that they are uniformly distributed within the gel matrix [27].

Surface functionalization of biopolymer gels can be modified by targeting ligands or affinity moieties to specifically bind a range of imaging agents to enhance their retention and localization in the gel Supervised.

Table 2. Examples of biopolymer-based imaging agents for theranostic applications.

Biopolymer-based imaging agents	Applications
Sugar-based biopolymers	These biopolymers have been recognized as attractive materials for developing macromolecule- and nanoparticle-based cancer imaging and therapy. They have been investigated for optical imaging using fluorescence dye-conjugates, nuclear imaging using Technetium 99m labeling for SPECT or Gallium 68 labeling for PET, and MR imaging using Gd-conjugates for generating T1-weighted contrast agents.	[28]
Biodegradable biopolymer-based nanoparticles	These nanoparticles are biocompatible, biodegradable, and generally non-toxic, making them suitable for healthcare applications. Examples include liposomes, polymersomes, micelles, polymer constructs, and protein complexes.	[27]
Biopolymer-based nanoparticles for cancer theranostics	These nanoparticles have been engineered to bear ligands with high affinity for specific cancer biomarkers, enabling targeted administration and real-time monitoring of treatment responses. They have also been designed to overcome biological barriers, such as the blood-brain barrier, and to facilitate immunomodulation strategies.	[29]
Functionalized nanomaterials for broad-spectrum theranostics	These nanomaterials have been developed for biomedical applications, including in vivo ultrasound-switchable fluorescence imaging and targeted delivery of diagnostic or therapeutic agents to tumors .	[13]
68 Ga-labeled biopolymer-based nanoparticles	These nanoparticles have been synthesized and characterized for receptor-targeted PET imaging agents, demonstrating their potential for detecting cancer cells in mouse models of ovarian cancer.	[30]
Marine biopolymer for theranostic applications	Marine biopolymers have been explored for their potential in theranostic applications, offering a novel platform for the development of imaging agents and therapeutic delivery systems.	[31]

Table 2. Examples of biopolymer-based imaging agents for theranostic applications.

Biopolymer-based imaging agents	Applications
Sugar-based biopolymers	These biopolymers have been recognized as attractive materials for developing macromolecule- and nanoparticle-based cancer imaging and therapy. They have been investigated for optical imaging using fluorescence dye-conjugates, nuclear imaging using Technetium 99m labeling for SPECT or Gallium 68 labeling for PET, and MR imaging using Gd-conjugates for generating T1-weighted contrast agents.	[28]
Biodegradable biopolymer-based nanoparticles	These nanoparticles are biocompatible, biodegradable, and generally non-toxic, making them suitable for healthcare applications. Examples include liposomes, polymersomes, micelles, polymer constructs, and protein complexes.	[27]
Biopolymer-based nanoparticles for cancer theranostics	These nanoparticles have been engineered to bear ligands with high affinity for specific cancer biomarkers, enabling targeted administration and real-time monitoring of treatment responses. They have also been designed to overcome biological barriers, such as the blood-brain barrier, and to facilitate immunomodulation strategies.	[29]
Functionalized nanomaterials for broad-spectrum theranostics	These nanomaterials have been developed for biomedical applications, including in vivo ultrasound-switchable fluorescence imaging and targeted delivery of diagnostic or therapeutic agents to tumors .	[13]
68 Ga-labeled biopolymer-based nanoparticles	These nanoparticles have been synthesized and characterized for receptor-targeted PET imaging agents, demonstrating their potential for detecting cancer cells in mouse models of ovarian cancer.	[30]
Marine biopolymer for theranostic applications	Marine biopolymers have been explored for their potential in theranostic applications, offering a novel platform for the development of imaging agents and therapeutic delivery systems.	[31]

These examples illustrate the versatility and potential of biopolymer-based imaging agents for theranostic applications, including their ability to be tailored for specific biomedical applications, their biocompatibility and biodegradability, and their potential for real-time monitoring of treatment responses.

9. Challenges in Conventional Drug Delivery Monitoring

Monitoring drug delivery through traditional techniques is primarily based on indirect measurements with reasonable limitations to quantifying fundamental aspects of drug delivery such as drug concentration in target organs and drug pharmacokinetic activity in a patient’s body. Common drawbacks of conventional methods are the absence of precision, invasive procedures, significant time delay, and poor sensitivity [34].

Spatial resolution with conventional monitoring approaches, such as blood sampling and tissue biopsies, are the most limiting, as they do not provide insight into localized drug distribution or concentration gradients in target tissues. In many cases, invasive procedures such as tissue sampling or catheter placement are required to monitor these techniques. These strategies may result in patient discomfort, the risk of infection, and procedural risks. Furthermore, the timing of the feedback, including drug delivery kinetics, is poor with conventional monitoring approaches. Currently, feedback is frequently obtained long after administration. Therefore, adjusting treatment or optimizing therapeutic work regimens is challenging [35].

10. Applications of Biopolymer Gel in Real Time Monitoring and Advancements

The incorporation of biopolymer gels into real-time monitoring techniques holds immense potential across various fields such as drug delivery, tissue engineering, and regenerative medicine. In targeted cancer therapy, biopolymer-based drug delivery systems enable precise delivery of therapeutic agents to tumor tissues, minimizing systemic toxicity and enabling individualized treatment plans based on real-time monitoring of drug delivery rhythms and tumor response. Moreover, biopolymer gels offer controlled drug release, making them ideal for long-term intervention therapy in chronic diseases like diabetes and heart disease, while also facilitating tissue regeneration and wound healing in regenerative medicine applications [36]. Real-time monitoring of drug release kinetics and tissue remodeling processes enhances therapeutic efficacy and enables customized treatment strategies tailored to individual patient needs.

Recent advancements in biopolymer gel formulations, imaging techniques, and monitoring technologies have propelled the development of next-generation theranostic systems for personalized medicine and healthcare. Hydrogels, nanogels, cryogels, and other emerging gel systems offer versatile platforms for controlled drug delivery, simultaneous imaging, and real-time analytical capabilities[37]. By leveraging the unique properties of these gel systems, researchers can develop innovative pharmaceutical strategies that combine drug delivery, imaging, and real-time monitoring, paving the way for personalized medicine, regenerative medicine, and precision healthcare approaches that optimize therapeutic outcomes for patients [38].

11. Future Outlook and Recommendations

Looking ahead, the future prospects for biopolymer gels in theranostic applications are promising, with continued advances in materials science, imaging technology, and biomedical engineering to realize the potential of biopolymer gels biocompatibility and stability issues in general, to increase imaging resolution and sensitivity, and to clinical interpretation and regulatory considerations It is important to address the major challenges.

12. Conclusions

Biopolymer gels have become highly adaptable platforms for theranostic applications, combining imaging, real-time monitoring, and drug administration into cohesive systems for personalised and precision treatment. These gels, which can include imaging agents, are biocompatible, have customisable characteristics, and are made of natural or synthetic polymers that crosslink to form networks that resemble the extracellular matrix. Imaging agents are included into biopolymer gels to allow for real-time drug delivery tracking, precise therapeutic control, and treatment result optimisation. The development of more advanced biopolymer gel systems with additional functionalities like stimuli responsiveness or self-healing qualities to further improve their therapeutic potential should be the main focus of future research efforts. These systems can be customised to particular biomedical applications.